Correction of Hypomimia Through Activation of Gait Function in Patients with Parkinson`s Disease
https://doi.org/10.31550/1727-2378-2023-22-6-78-82
Abstract
Aim: To assess the influence of gait function activation on manifestations of hypomimia in patients with Parkinson's disease (PD).
Design: A comparative clinical study.
Materials and methods. The study enrolled 18 patients with stage of 2–3 PD according to Hoehn — Yahr Rating Scale aged 70 [65; 76] years. Analysis of facial expression in PD patients was analysed by using a proprietary method of computer video-analysis of facial muscle movement. Activation of the gait function used another proprietary method: the apparatus for functional foot therapy that mechanically activates the rear push of the foot at the moment of the lift of the foot from the supporting surface.
Results. Activation of the gait function has statistically significantly improved the mimic function of the face, in particular the blink frequency (p = 0.022), eyebrow movement amplitude along the Y axis in the «brow furrow» test (p = 0.048) and the amplitude of mouth movement while reading a text along the axis X (p = 0.012).
Conclusion. The confirmation of the decrease of hypomimia manifestations through affecting the condition of general hypokinesia creates the prerequisites for appearance of rehabilitation methods making it possible to perform simultaneously correction of these two symptoms.
About the Authors
A. A. Khomchenkova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak Str., Krasnoyarsk, 660022
S. V. Prokopenko
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak Str., Krasnoyarsk, 660022
S. B. Ismailova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak Str., Krasnoyarsk, 660022
Yu. N. Ashikhmina
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak Str., Krasnoyarsk, 660022
E. S. Denisova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
1 Partizan Zheleznyak Str., Krasnoyarsk, 660022
References
1. Kucherova O.G. On the etiology, diagnosis, and current treatment of Parkinson's disease. Brain Universe. 2020;2(2):24–26. (in Russian)
2. Bologna M., Paparella G., Fasano A., Hallett M. et al. Evolving concepts on bradykinesia. Brain. 2020;143(3):727–50. DOI: 10.1093/brain/awz344
3. Prenger M.T.M., Madray R., Van Hedger K., Anello M. et al. Social symptoms of Parkinson’s disease. Parkinsons Dis. 2020;2020:8846544. DOI: 10.1155/2020/8846544
4. García-Ruiz P.J., Feliz-Feliz C.E., Maycas- Cepeda T., Del Val-Fernández J. Amimia en la enfermedad de Parkinson. Significado y correlación con la clínica. Revista de Neurologia. 2018;66:45–8. DOI: 10.33588/rn.6602.2017387
5. Saçmacı H., Erkoç M.F., Aktürk T. Measurement of the facial nerve thickness and its correlation with freezing phenomenon and hypomimia in Parkinson’s disease. Clin. Neurol. Neurosurg. 2021;210:106960. DOI: 10.1016/j.clineuro.2021.106960
6. Maycas-Cepeda T., López-Ruiz P., Feliz-Feliz C., Gómez-Vicente L. et al. Hypomimia in Parkinson’s disease: what is it telling us? Front. Neurol. 2021;11:603582. DOI: 10.3389/fneur.2020.603582
7. Tappakhov A.A., Popova T.E., Govorova T.G., Khabarova Yu.I. et al. Pharmacokinetics of levodopa and personalized therapy in Parkinson’s disease. Practical Medicine. 2020;18(5):36–41. (in Russian)
8. Levin O.S., Chimagomedova A.S., Yakovleva O.V. Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia. Medical Council. 2020;19:31–40. (in Russian). DOI: 10.21518/2079-701X-2020-19-31-40
9. Ricciardi L., De Angelis A., Marsili L., Faiman I. et al. Hypomimia in Parkinson’s disease: an axial sign responsive to levodopa. Eur. J. Neurology. 2020;27(12):2422–9. DOI: 10.1111/ene.14452
10. Natalevich S.P., Kalinin V.A., Poverennova I.E., Shpileva S.A. et al. The use of virtual reality in treatment of gait disorders in patients with Parkinson's disease. Saratov Journal of Medical Scientific Research. 2021;17(1):132–6. (in Russian)
11. I.G. Smolentseva, N.A. Amosova, A. V. Kuzmina. Rehabilitation of Parkinson disease patients: current status and outlooks. Byulleten' Nacional'nogo obshchestva po izucheniyu bolezni Parkinsona i rasstrojstv dvizhenij. 2022;2:188–93. (in Russian). DOI: 10.24412/2226-079X-2022-12464
12. T.V. Lvova. Music therapy in Parkinson disease patients. Chelovek. Socium. Obshchestvo. 2022;S13:28–31. (in Russian)
13. Ma H.I., Gunnery S.D., Stevenson M.T., Saint-Hilaire M. et al. Experienced facial masking indirectly compromises quality of life through stigmatization of women and men with Parkinson’s disease. Stigma Health. 2019;4(4):462–72. DOI: 10.1037/sah0000168
14. Ricciardi L., Baggio P., Ricciardi D., Morabito B. et al. Rehabilitation of hypomimia in Parkinson’s disease: a feasibility study of two different approaches. Neurol.Sci. 2016;37(3):431–6. DOI: 10.1007/s10072-015-2421-9
15. Dumer A.I., Oster H., McCabe D., Rabin L.A. et al. Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease. J. Int. Neuropsychol. Soc. 2014;20(3):302–12. DOI: 10.1017/S1355617714000046
16. Khomchenkova A.A., Prokopenko S.V., Ismailova S.B. Clinical aspects of hypomimia in Parkinson’s disease. Neurology Bulletin. 2022;54(1):45–53. (in Russian). DOI: 10.17816/nb89531
17. Ismailova S.B., Ondar V.S., Churakova K.V., Prokopenko S.V. Walking pathological stereotype correction in Parkinson disease. Bulletin of the Ivanovo Medical Academy. 2018;23(4):18–21. (in Russian). DOI: 10.24412/fdvzrbppv5g
18. Ismailova S.B., Ondar V.S., Yermilov E.A., Churakova K.V. et al. The new approach in the treatment of walking disorders in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10):46–50. (in Russian). DOI: 10.17116/jnevro201911910146
19. Palermo G., Giannoni S., Bellini G., Siciliano G. et al. Dopamine transporter imaging, current status of a potential biomarker: a comprehensive review. Int. J. Mol. Sci. 2021;22(20):11234. DOI: 10.3390/ijms222011234
20. Mäkinen E., Joutsa J., Jaakkola E., Noponen T. et al. Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT. J. Neurol. 2019;266(4):826–34. DOI: 10.1007/s00415-019-09202-6
21. Lange K.W., Robbins T.W., Marsden C.D., James M. et al. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology. 1992;107(2–3):394–404. DOI: 10.1007/bf02245167
22. Vasenina E.E., Levin O.S. Heterogeneity of speech disorders in Parkinson’s disease: potential for classification, diagnostics and therapy. Medical Council. 2020;2:49–60. (in Russian). DOI: 10.21518/2079-701X-2020-2-55-66
23. Kumar S., Goyal L., Singh S. Tremor and rigidity in patients with Parkinson’s disease: Emphasis on epidemiology, pathophysiology and contributing factors. CNS Neurol. Disord. Drug Targets. 2022;21(7):596–609. DOI: 10.2174/1871527320666211006142100
24. Novotný M., Dušek P., Daly I., Růžička E. et al. Glottal source analysis of voice deficits in newly diagnosed drug-naïve patients with Parkinson’s disease: correlation between acoustic speech characteristics and non-speech motor performance. Biomedical Signal Processing and Control. 2020;57:101818. DOI: 10.1016/j.bspc.2019.101818
25. Novotný M., Tykalova Т., Ruzickova Н., Růžička E. et al. Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease. NPJ Digit. Med. 2022;5(1):98. DOI: 10.1038/s41746-022-00642-5
26. Pasquini J., Pavese N. Striatal dopaminergic denervation and hypomimia in Parkinson's disease. Eur. J. Neurol. 2021;28(1):e2–3. DOI: 10.1111/ene.14483
27. Ismailova S.B., Prokopenko S.V., Pokhabov D.V., Mosaleva E.I. et al. Dynamics of cognitive impairments during L-dopa therapy in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(7): 36–41. (in Russian). DOI: 10.17116/jnevro202112107136
28. Mortimer J.A., Pirozzolo F.J., Hansch E.C., Webster D.D. Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology. 1982;32(2):133–7. DOI: 10.1212/WNL.32.2.133
29. Wang Q., Meng L., Pang J., Zhu X. et al. Characterization of EEG data revealing relationships with cognitive and motor symptoms in Parkinson's disease: a systematic review. Front. Aging Neurosci. 2020;12:587396. DOI: 10.3389/fnagi.2020.587396
30. Mosaleva E.I., Zhumzhanov I.M., Alekseenko P.V., Ismailova S.B. et al. Cognitive fluctuations associated with therapy in patients with Parkinson diseases. Siberian Medical Review. 2020; 6:63–7. (in Russian). DOI: 10.20333/2500136-2020-6-63-67
Review
For citations:
Khomchenkova A.A., Prokopenko S.V., Ismailova S.B., Ashikhmina Yu.N., Denisova E.S. Correction of Hypomimia Through Activation of Gait Function in Patients with Parkinson`s Disease. Title. 2023;22(6):78-82. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-6-78-82
Views:
7
Email this article 